Personalized Medicine Market Research Reports & Industry Analysis
Personalized medicine is transforming how we approach medical treatments and patient care by offering greater accuracy, efficacy, and safety. MarketResearch.com provides a selection of reports on the personalized medicine and precision medicine industry to help you get up to speed quickly and build effective long-term strategies in this space.
Precision and Personalized Medicine Market Data
- Use our reports to understand key technologies, use cases, regulatory trends, deals, and other critical topics.
- Gain access to personalized medicine market sizing and growth forecasts, as well as value chain analysis.
- Read expert predictions about how the market will evolve and identify the companies most likely to weather disruptive threats.
Trusted Expertise
Whether you are exploring new markets or advising an important client, our reports serve as a practical guide to inform your decisions. With a dedication to delivering quality research from top market research firms globally, MarketResearch.com has been a reliable partner for organizations throughout the value chain for decades. Browse our list of personalized medicine market research reports to gain the knowledge needed for success.
Personalized Medicine Industry Research & Market Reports
-
Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2030
... reach USD 59.94 billion by 2030 from USD 4.47 billion in 2025, at a CAGR of 68.0% during the forecast period. Public and private entities increasingly invest in digital twin technologies, recognizing their potential to ... Read More
-
Precision Medicine Market By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics) By Indication (Oncology, CNS, Immunology, Respiratory diseases, Genetic disorders, Skin diseases, Others) By Application (Diagnostics {Genetic Tests, Biomarker Based Tests, Esoteric Tests} Therapeutics {Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & anti-retroviral Drugs, Others) By End-user (Hospitals, Diagnostic Laboratories, Others) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
... Esoteric Tests} Therapeutics {Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & anti-retroviral Drugs, Others) By End-user (Hospitals, Diagnostic Laboratories, Others) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles ... Read More
-
Global Genetic Testing Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Emerging Opportunities for Quantum Sensing in Healthcare
... easier and non-intrusive monitoring, and producing better images than conventional systems. The integration of quantum sensing into AI offers further enhancement in real-time data analysis and predictive modeling for targeted treatment options and further healthcare ... Read More
-
Precision Medicine
... CAGR of 8.7% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$89.0 Billion by the end of the analysis period. ... Read More
-
Precision Medicine Software
... at a CAGR of 10.0% over the analysis period 2024-2030. On-Premise, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
... rising prevalence of chronic diseases, ongoing developments in biotechnology and genomics, the shift toward personalized medicine, continuous advancements in analytical technologies, and increasing awareness among both healthcare professionals and patients about the benefits of biomarkers ... Read More
-
Predictive Diagnostics
... CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$821.4 Million While China is Forecast to Grow at 9.9% CAGR The Predictive Diagnostics market in the U.S. is estimated at ... Read More
-
Personalized Medicines
... CAGR of 4.6% over the analysis period 2024-2030. Personalized Nutrition & Wellness, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$484.0 Billion by the end of ... Read More
-
2025 Global Genomics Personalized Health Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
Personalized Nutrition
... CAGR of 13.5% over the analysis period 2024-2030. Active Measurement, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$27.5 Billion by the end of the analysis ... Read More
-
Personalized Genomics Market, By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, Others), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk ... Read More
-
High End Cellomics Market, By Product Type (Instruments, Reagents and Consumables, and Software & Services), By Application (Drug discovery, Cancer Research, Neuroscience, Stem Cell Research and Regenerative Medicine, Personalized Medicine, and Others), By Technology (Microscopy, Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... for the study of cells at a molecular level. These technologies enable scientists and researchers to analyze cell structure, function, and dynamics, leading to important advancements in various fields such as drug discovery, disease diagnosis, ... Read More
-
Oncology Precision Medicine Market by Type of Cancer Targeted
... CAGR of 8.5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Cancer Targeted Bladder Cancer Blood / Hematologic Cancer Breast Cancer Cervical ... Read More
-
The Next Frontier of Healthtech Innovation
... to rise, driven by factors such as aging populations, prevalence of chronic diseases, and increasing costs of treatments, healthtech offers ways to make healthcare more affordable and sustainable. Healthtech provides an opportunity to make healthcare ... Read More
-
Tumor Profiling Market Size, Share, and Outlook, 2025 Report- By Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Others), By Biomarker, Genomic Biomarker, Protein Biomarker), By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Tumor Profiling segments across 22 countries from 2021 to 2032. ... Read More
-
Global Nucleic Acid Methylation Market Size Study, By Product & Services (Kits & Reagents, Enzymes, Services, Instruments & Software, Consumables), By Type (DNA Methylation, RNA Methylation), By Technology (Next-Generation Sequencing, PCR-Based Techniques, Mass Spectrometry, Microarray-Based Methylation Analysis, Others), By Application (Drug Discovery & Personalized Medicines, Clinical Diagnostics, Others), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories), and Regional Forecasts 2022-2032
... the increasing role of DNA and RNA methylation in precision medicine, cancer research, and drug discovery, as well as advancements in sequencing technologies and AI-driven data analysis. The growing demand for epigenetics-based diagnostics and the ... Read More
-
Global Multiomics Market, By Product & Service (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as ... Read More
-
Personalized Medicine Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Precision Medicine Market Size, Share, By Type (Diagnostics, Therapeutics, and Others), Technology (Bioinformatics, Drug Discovery, Gene Sequencing, Precision Molecular Diagnostics, Big Data Analytics, and Others), Application (Oncology, CNS, Respiratory, Immunology, Hematology, and Others), End-User (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, and Others), and Region - Trends, Analysis, and Forecast till 2035
... and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, and Others), and Region - Trends, Analysis, and Forecast till 2035 The Precision Medicine Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, ... Read More
-
Artificial Intelligence (AI) in Precision Medicine Global Market Report 2025
... artificial intelligence (ai) in precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to ... Read More
-
Blood Cell Separation Market Size, Share, By Product (Consumables, and Instruments), Cell Type (Human Cells, Animal Cells, and Others), Technique (Centrifugation-based Cell Isolation, Surface marker-based Cell Isolation, and Filtration-based Cell Isolation), Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In-vitro Diagnostics, and Others), End-User (Research Laboratories and Institutes, Hospitals, and Others), and Region - Trends, Analysis and Forecast till 2035
... Research, Stem Cell Research, In-vitro Diagnostics, and Others), End-User (Research Laboratories and Institutes, Hospitals, and Others), and Region - Trends, Analysis and Forecast till 2035 The market is driven by the increasing use of cell ... Read More
-
Multi-Cancer Early Detection Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample Type, End User, and Region - Forecast, 2024-2034
... compound annual growth rate (CAGR) of 16.30% over the period from 2024 to 2034. The market has been experiencing significant growth, primarily fuelled by the rising global cancer burden, increasing demand for early diagnosis, and ... Read More
-
Metabolomics Technologies Market Size, Share, By Technology (Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, Chromatography, and Other Technologies), By Application (Biomarker And Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, and Other Applications), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Agricultural and Environmental Organizations), and By Region - Trends, Analysis and Forecast till 2034
... share, by top players, by type, by the end user, and by region. Metabolomics Technologies Market Size Statistics The metabolomics technologies market size to be Worth USD 51.08 Billion by 2034. The market was valued ... Read More
-
Global Sanger Sequencing Market, By Type (Shotgun Sequencing, Targeted Gene Sequencing, and Others), By Application (Diagnostics, Personalized Medicine, Forensics, and Others), By End-use (Government Research Institutes, Diagnostic Labs, Pharmaceutical and Biotechnology Company, and Others), and Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... by a British biochemist, Mr. Frederick Sanger in 1977, revolutionized DNA sequencing and enabled rapid progress in genetics and genomics. Sanger sequencing produces high-quality DNA sequences in both directions and is considered the gold standard ... Read More
Research Assistance
